ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Antibody Titers as Predictors of Kidney Graft Outcomes.

A. Gilbert,1 M. Zaheer,1 O. Timofeeva,2 S. Rosen-Bronson,2 M. Awwad,2 D. Li,2 M. Grafals,1 B. Javaid,1 P. Abrams,1 J. Verbesey,1 M. Cooper.1

1Surgery, MedStar Georgetown Transplant Institute, Washington, DC
2Pathology, MedStar Georgetown Transplant Institute, Washington, DC.

Meeting: 2016 American Transplant Congress

Abstract number: C19

Keywords: HLA antibodies, Kidney transplantation, Rejection

Session Information

Date: Monday, June 13, 2016

Session Name: Poster Session C: Antibody Mediated Rejection: Session #1

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Assessment of Anti-A and Anti-B Antibody Titers in Different IVIG Preparations: Correlation with Risk for Hemolysis
  • The Value of Surveillance Testing for De Novo Donor Specific Antibodies Following Renal Transplantation

PURPOSE: Development of de novo donor specific antibody (dnDSA) following kidney transplantation is not uncommon. As laboratory techniques advance, rates of dnDSA have increased. However, with more sensitive techniques, questions arise as to the significance of these antibodies. Mean fluorescence intensity (MFI) has shown inconsistent results. We looked at antibody dilutions as an alternative method of identifying significant antibodies.

METHODS: We retrospectively analyzed data for all patients who have developed dnDSA since our current screening program began in January 2012. Antibodies were reported by MFI and the lowest titer at which they could be identified. Patients were analyzed by class of DSA, time to development, c1q positivity, titer, coincident change in renal function, biopsy findings, and antibody treatment. Statistical calculations were made using Fisher's exact test with a two tailed P value.

RESULTS: 91 patients were analyzed who had developed dnDSA following kidney or kidney/pancreas transplantation. 54 had titers of 1:64 or less, 37 had titers of 1:128 or greater. The low titer antibody group was associated with significantly better outcomes including reduction in or complete resolution (CR) of antibody (54% vs 19% p= 0.001 for CR, 74% vs 49% p= 0.016 for reduction) as well as a better chance to return to baseline renal function (85 v. 51% p= 0.0003).

The low titer group was associated with less aggressive treatment (46 v. 81% p=0.001). It also was more likely to be c1q negative (88 v. 22% p=0.0001), occur within 6 months of transplant ( 76 v. 54% p=0.04), be limited to class I antibodies (52 v. 14% p=0.0002), and not be associated with an elevation in creatinine (81 v. 54% p=0.04). Each of these variables was also analyzed as possible confounders, but with the exception of elevation in creatinine, none were found to be significant independent predictors of outcome.

Other cutoffs for antibody titer were similarly analyzed, but none showed a statistically significant impact on clinical or serologic outcomes.

CONCLUSION: Antibody titer, more than MFI, is a useful tool to help identify antibodies which have greater risk to the patient and graft. Titer was a better predictor of this than time to development, c1q positivity or antibody class.

CITATION INFORMATION: Gilbert A, Zaheer M, Timofeeva O, Rosen-Bronson S, Awwad M, Li D, Grafals M, Javaid B, Abrams P, Verbesey J, Cooper M. Antibody Titers as Predictors of Kidney Graft Outcomes. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Gilbert A, Zaheer M, Timofeeva O, Rosen-Bronson S, Awwad M, Li D, Grafals M, Javaid B, Abrams P, Verbesey J, Cooper M. Antibody Titers as Predictors of Kidney Graft Outcomes. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/antibody-titers-as-predictors-of-kidney-graft-outcomes/. Accessed March 8, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Search
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Home
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.